Federal award
THE CLEVELAND CLINIC FOUNDATION
N6600115C4015
Contract
Obligated and Ceiling
- Obligated (net)
- $2,181,786.00
- Ceiling (potential value, not spending)
- $2,508,355.00
- Current value
- $2,181,786.00
- Gross positive obligations
- $2,181,786.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- THE CLEVELAND CLINIC FOUNDATION · TDGUJ1WA4UJ9
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- THE CLEVELAND CLINIC FOUNDATION · TDGUJ1WA4UJ9
- Awarding agency
- Department of War · sub-agency 1700 · office N66001
- Funding agency
- Department of War · sub-agency 97AE
- Product or service (PSC)
- AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- N6600115C4015
- Award type code
- D
- Actions
- 9 · Jan 30, 2015 to Jan 17, 2019
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History9
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 17, 2019 | FY2019 | P00008 | M | $0.00 | — |
| Dec 17, 2018 | FY2019 | P00007 | C | $153,729.00 | — |
| Dec 20, 2017 | FY2018 | P00006 | B | $336,727.00 | — |
| Dec 19, 2016 | FY2017 | P00005 | C | $508,680.00 | — |
| Jul 27, 2016 | FY2016 | P00004 | B | $200,000.00 | — |
| Mar 16, 2016 | FY2016 | P00003 | B | $131,456.00 | — |
| Nov 23, 2015 | FY2016 | P00002 | C | $321,680.00 | — |
| Sep 25, 2015 | FY2015 | P00001 | M | $276,102.00 | — |
| Jan 30, 2015 | FY2015 | 0 | — | $253,412.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.
